The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Therapeutic Plasma Exchange-Global Market Insights and Sales Trends 2024
Synopsis
Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely performed in the treatment of various chronic diseases as first line or as second line of therapy or as a supportive treatment.
The global Therapeutic Plasma Exchange market size is expected to reach US$ 326.3 million by 2029, growing at a CAGR of 9.3% from 2023 to 2029. The market is mainly driven by the significant applications of Therapeutic Plasma Exchange in various end use industries. The expanding demands from the Hospitals, Specialty Clinics and Ambulatory Surgical Centers,, are propelling Therapeutic Plasma Exchange market. Neurological Disorders, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Renal Disorders segment is estimated at % CAGR for the next seven-year period.
Therapeutic plasma exchange (TPE) has wide applications in the treatment of neurological, renal, hematological, and metabolic disorders. The indications for using therapeutic plasma exchange procedures as a line of treatment are regulated through guidelines provided by the American Society for Apheresis (ASFA). It categorizes the indications in four parts: category I to IV. Category I and II depict TPE as first or second line of treatment for many neurological, renal, and hematological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura (TTP).
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Therapeutic Plasma Exchange, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Therapeutic Plasma Exchange market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Therapeutic Plasma Exchange market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Therapeutic Plasma Exchange sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Therapeutic Plasma Exchange covered in this report include Asahi Kasei, Baxter International, Terumo, B. Braun, Fresenius Kabi, Kawasumi Laboratories, Haemonetics, Cerus and Hemacare, etc.
The global Therapeutic Plasma Exchange market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Asahi Kasei
Baxter International
Terumo
B. Braun
Fresenius Kabi
Kawasumi Laboratories
Haemonetics
Cerus
Hemacare
Medica
Global Therapeutic Plasma Exchange market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Therapeutic Plasma Exchange market, Segment by Type:
Neurological Disorders
Renal Disorders
Hematology Disorders
Metabolic Disorders
Others
Global Therapeutic Plasma Exchange market, by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Therapeutic Plasma Exchange companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely performed in the treatment of various chronic diseases as first line or as second line of therapy or as a supportive treatment.
The global Therapeutic Plasma Exchange market size is expected to reach US$ 326.3 million by 2029, growing at a CAGR of 9.3% from 2023 to 2029. The market is mainly driven by the significant applications of Therapeutic Plasma Exchange in various end use industries. The expanding demands from the Hospitals, Specialty Clinics and Ambulatory Surgical Centers,, are propelling Therapeutic Plasma Exchange market. Neurological Disorders, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Renal Disorders segment is estimated at % CAGR for the next seven-year period.
Therapeutic plasma exchange (TPE) has wide applications in the treatment of neurological, renal, hematological, and metabolic disorders. The indications for using therapeutic plasma exchange procedures as a line of treatment are regulated through guidelines provided by the American Society for Apheresis (ASFA). It categorizes the indications in four parts: category I to IV. Category I and II depict TPE as first or second line of treatment for many neurological, renal, and hematological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura (TTP).
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Therapeutic Plasma Exchange, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Therapeutic Plasma Exchange market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Therapeutic Plasma Exchange market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Therapeutic Plasma Exchange sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Therapeutic Plasma Exchange covered in this report include Asahi Kasei, Baxter International, Terumo, B. Braun, Fresenius Kabi, Kawasumi Laboratories, Haemonetics, Cerus and Hemacare, etc.
The global Therapeutic Plasma Exchange market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Asahi Kasei
Baxter International
Terumo
B. Braun
Fresenius Kabi
Kawasumi Laboratories
Haemonetics
Cerus
Hemacare
Medica
Global Therapeutic Plasma Exchange market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Therapeutic Plasma Exchange market, Segment by Type:
Neurological Disorders
Renal Disorders
Hematology Disorders
Metabolic Disorders
Others
Global Therapeutic Plasma Exchange market, by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Therapeutic Plasma Exchange companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Therapeutic Plasma Exchange
1.1 Therapeutic Plasma Exchange Market Overview
1.1.1 Therapeutic Plasma Exchange Product Scope
1.1.2 Therapeutic Plasma Exchange Market Status and Outlook
1.2 Global Therapeutic Plasma Exchange Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Therapeutic Plasma Exchange Market Size by Region (2018-2029)
1.4 Global Therapeutic Plasma Exchange Historic Market Size by Region (2018-2023)
1.5 Global Therapeutic Plasma Exchange Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Therapeutic Plasma Exchange Market Size (2018-2029)
1.6.1 North America Therapeutic Plasma Exchange Market Size (2018-2029)
1.6.2 Europe Therapeutic Plasma Exchange Market Size (2018-2029)
1.6.3 Asia-Pacific Therapeutic Plasma Exchange Market Size (2018-2029)
1.6.4 Latin America Therapeutic Plasma Exchange Market Size (2018-2029)
1.6.5 Middle East & Africa Therapeutic Plasma Exchange Market Size (2018-2029)
2 Therapeutic Plasma Exchange Market by Type
2.1 Introduction
2.1.1 Neurological Disorders
2.1.2 Renal Disorders
2.1.3 Hematology Disorders
2.1.4 Metabolic Disorders
2.1.5 Others
2.2 Global Therapeutic Plasma Exchange Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Therapeutic Plasma Exchange Historic Market Size by Type (2018-2023)
2.2.2 Global Therapeutic Plasma Exchange Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Therapeutic Plasma Exchange Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Therapeutic Plasma Exchange Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Therapeutic Plasma Exchange Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Therapeutic Plasma Exchange Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Therapeutic Plasma Exchange Revenue Breakdown by Type (2018-2029)
3 Therapeutic Plasma Exchange Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialty Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Therapeutic Plasma Exchange Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Therapeutic Plasma Exchange Historic Market Size by Application (2018-2023)
3.2.2 Global Therapeutic Plasma Exchange Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Therapeutic Plasma Exchange Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Therapeutic Plasma Exchange Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Therapeutic Plasma Exchange Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Therapeutic Plasma Exchange Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Therapeutic Plasma Exchange Revenue Breakdown by Application (2018-2029)
4 Therapeutic Plasma Exchange Competition Analysis by Players
4.1 Global Therapeutic Plasma Exchange Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Plasma Exchange as of 2022)
4.3 Date of Key Players Enter into Therapeutic Plasma Exchange Market
4.4 Global Top Players Therapeutic Plasma Exchange Headquarters and Area Served
4.5 Key Players Therapeutic Plasma Exchange Product Solution and Service
4.6 Competitive Status
4.6.1 Therapeutic Plasma Exchange Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Asahi Kasei
5.1.1 Asahi Kasei Profile
5.1.2 Asahi Kasei Main Business
5.1.3 Asahi Kasei Therapeutic Plasma Exchange Products, Services and Solutions
5.1.4 Asahi Kasei Therapeutic Plasma Exchange Revenue (US$ Million) & (2018-2023)
5.1.5 Asahi Kasei Recent Developments
5.2 Baxter International
5.2.1 Baxter International Profile
5.2.2 Baxter International Main Business
5.2.3 Baxter International Therapeutic Plasma Exchange Products, Services and Solutions
5.2.4 Baxter International Therapeutic Plasma Exchange Revenue (US$ Million) & (2018-2023)
5.2.5 Baxter International Recent Developments
5.3 Terumo
5.3.1 Terumo Profile
5.3.2 Terumo Main Business
5.3.3 Terumo Therapeutic Plasma Exchange Products, Services and Solutions
5.3.4 Terumo Therapeutic Plasma Exchange Revenue (US$ Million) & (2018-2023)
5.3.5 B. Braun Recent Developments
5.4 B. Braun
5.4.1 B. Braun Profile
5.4.2 B. Braun Main Business
5.4.3 B. Braun Therapeutic Plasma Exchange Products, Services and Solutions
5.4.4 B. Braun Therapeutic Plasma Exchange Revenue (US$ Million) & (2018-2023)
5.4.5 B. Braun Recent Developments
5.5 Fresenius Kabi
5.5.1 Fresenius Kabi Profile
5.5.2 Fresenius Kabi Main Business
5.5.3 Fresenius Kabi Therapeutic Plasma Exchange Products, Services and Solutions
5.5.4 Fresenius Kabi Therapeutic Plasma Exchange Revenue (US$ Million) & (2018-2023)
5.5.5 Fresenius Kabi Recent Developments
5.6 Kawasumi Laboratories
5.6.1 Kawasumi Laboratories Profile
5.6.2 Kawasumi Laboratories Main Business
5.6.3 Kawasumi Laboratories Therapeutic Plasma Exchange Products, Services and Solutions
5.6.4 Kawasumi Laboratories Therapeutic Plasma Exchange Revenue (US$ Million) & (2018-2023)
5.6.5 Kawasumi Laboratories Recent Developments
5.7 Haemonetics
5.7.1 Haemonetics Profile
5.7.2 Haemonetics Main Business
5.7.3 Haemonetics Therapeutic Plasma Exchange Products, Services and Solutions
5.7.4 Haemonetics Therapeutic Plasma Exchange Revenue (US$ Million) & (2018-2023)
5.7.5 Haemonetics Recent Developments
5.8 Cerus
5.8.1 Cerus Profile
5.8.2 Cerus Main Business
5.8.3 Cerus Therapeutic Plasma Exchange Products, Services and Solutions
5.8.4 Cerus Therapeutic Plasma Exchange Revenue (US$ Million) & (2018-2023)
5.8.5 Cerus Recent Developments
5.9 Hemacare
5.9.1 Hemacare Profile
5.9.2 Hemacare Main Business
5.9.3 Hemacare Therapeutic Plasma Exchange Products, Services and Solutions
5.9.4 Hemacare Therapeutic Plasma Exchange Revenue (US$ Million) & (2018-2023)
5.9.5 Hemacare Recent Developments
5.10 Medica
5.10.1 Medica Profile
5.10.2 Medica Main Business
5.10.3 Medica Therapeutic Plasma Exchange Products, Services and Solutions
5.10.4 Medica Therapeutic Plasma Exchange Revenue (US$ Million) & (2018-2023)
5.10.5 Medica Recent Developments
6 North America
6.1 North America Therapeutic Plasma Exchange Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Therapeutic Plasma Exchange Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Plasma Exchange Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Therapeutic Plasma Exchange Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Plasma Exchange Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Therapeutic Plasma Exchange Market Dynamics
11.1 Therapeutic Plasma Exchange Industry Trends
11.2 Therapeutic Plasma Exchange Market Drivers
11.3 Therapeutic Plasma Exchange Market Challenges
11.4 Therapeutic Plasma Exchange Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
